Health Archive » February, 2022

Health - February, 2022

384 articles

• Flint Water Engineers Were 'Puzzle Pieces' Of Crisis, Jury Told
• Endo, Arnold & Porter Opioid Discovery Called 'Truly Awful'
• Mylan Inks $264M Deal Ending EpiPen Class Price-Hike Suit
• Anthem Must Face ERISA Suit Over Mental Health Coverage
• Abortion Rights Bill Fails In Senate As Roe's Future In Limbo
• The Battle To Confirm Ketanji Brown Jackson
• Chicago Firm Files Class Actions Over Medical Records Costs
• Hartford HealthCare Looks To Toss Antitrust Suit
• Smith & Nephew Gets Claims Trimmed In Hip Implant MDL
• GOP Sens. Ask HHS To Nix 'Toxic' Bid To Seize Cancer Drug IP
• Cravath, Goodwin Pilot Viatris' Up To $3.34B Biosimilars Deal
• Opana Buyers Want Pay-For-Delay Trial Split In 3
• 2 More SPACs Pull IPOs Totaling $400M As Withdrawals Mount
• Texas Justices Nix Early Discovery In Medical Malpractice Suit
• 3rd Circ. Preview: March Roars With Ch. 11, Poaching Spats
• Ex-Worker Says Amazon's Health Benefit Notices 'Threatening'
• Bankrupt Stem Cell Biz To Pay $3.65M In Class Settlement
• Bankruptcy Is Optimal Venue For Mass Tort Cases
• Hunton, McDermott Shape $18B Merger Of Health Care REITs
• Party Leaders Vow Open Minds For New High Court Pick
• Sutter Exec Pressed On COVID Care In $411M Antitrust Trial
• DOJ Has Few Allies, Many Foes In High Court Opioid Brawl
• How Judge Jackson Beat Out Competition For High Court Nod
• Why Ketanji Brown Jackson Honored This Historic Judge
• 1st Circ. Judge Selya Says Jackson Will Be 'Balanced'
• Edited Med Mal Claims Can Still Trigger Texas Expert Deadline
• Cannabis Bill Roundup: Legalization Bids Advance In SD, Md.
• Zetia Buyers Get Narrow Market In Generic-Delay Suit
• 1st Circ. Revives Medical Malpractice Suit Over Court Error
• Brand Battles: BetterUp Takes Aim At 'BetterHelp' Trademark
• UnitedHealthcare Must Revisit Mental Health Claim Denials
• Litigator Makes Move From Bartlit Beck To Winston & Strawn
• Stericycle Takes $81M Hit On Bribery Deal With DOJ, SEC
• Biden's Supreme Court Pick Was Star Debater In Miami
• The Key To Turning Solid Briefs Into Winning Briefs
• What's At Stake In Doctors' Opioid Liability Case In High Court
• Generic-Drug Maker Takes Novartis Battle To Full Fed. Circ.
• ABI Panelists, US Chamber Support Ch. 11 3rd-Party Releases
• J&J, Drug Distributors' $26B Opioid Settlement Is Finalized
• The Big Picture: COVID Coverage Cases In Fed. Appeals Court
• J&J Talc Unit's Ch. 11 Case Allowed To Go Forward
• 6 Judge Ketanji Brown Jackson Opinions To Read Now
• Biden Nominates Judge Ketanji Brown Jackson To High Court
• Bill Paxton's Family Inks $1M Deal With Anesthesia Group
• Ga. County Likely Can't Avoid Trial In Trans Deputy's Bias Suit
• Hartford Unit Beats Dental Office's COVID-19 Coverage Claims
• Anthem BCBS Gets Trans Worker's Discrimination Suit Tossed
• Teligent Says Stalled Plan Talks Make Liquidation Best Option
• Biden Seeks To Boost Domestic Production In New Plan
• UK Finance Minister Wants To Cut Taxes, Resist Intervention
• Atty's Improper Closing Voids Hospital Win In Infant Care Trial
• Steps For Universities As DOJ Shifts Foreign Influence Policy
• FDA Commits To Compounding Drug Rulemaking
• Calif.'s Top Court OKs Med Mal Cap, Slashed $4.3M Award
• Health Workers Can't Get Freeze On NY Vaccine Mandate
• UnitedHealth Unit Pays $5.8M To End Mass. Drug Price Probe
• SDNY Mootness Fee Refusal May Shake Up A Common Tactic
• Texas Can Break With High Court On Abortion Law, State Says
• Ex-Patriots Player, Feds Strike Restitution Deal In COVID Scam
• Medtronic Can't Shake Illegal Kickback Suit
• Indian Health Care Biz MediBuddy Lands $125M In Funding
• Racehorse Trainer Snared In Doping Scandal Gets 3 Years
• DOJ Challenges UnitedHealth's $13.8B Change Deal
• Texas Judge Rejects HHS Rule On Surprise Medical Billing
• Sutter's Market Dominance Hiked Premiums $411M, Jury Told
• Telehealth Fraud Not An Easy FCA Target, DOJ Attys Say
• Trade Org Urges Gov't Action On Hemp-Derived Intoxicants
• NM Justices Turn Down Petition, Let Medical Pot Stay Untaxed
• Optum And Oxford Win Drug Pricing ERISA Suit
• Pfizer Drops Case Alleging Ex-Employee Stole Pharma Data
• Pandemic Deemed No Excuse For Late Med Mal Expert Filing
• Texas Court Debates Discretion In Periodic Payment Awards
• Asarco Wins Toss Of Retiree Health Benefits Class Action
• Walgreens, Drugmakers Can't Get Stay In Opioid Bellwether
• How Health Care Cos. Can Prepare For DOJ's Cyberfraud Push
• Del. Judge Says No Break For Insurer On $5M Settlement Error
• Va. Medical Center's Virus Coverage Suit Survives
• US Says Gulf Coast Unclear On Fate Of Pandemic Payments
• 9th Circ. Orders BIA To Revisit Mexican's Abuse Claims
• Sutter Dominated Market; Employers Wanted It, Jurors Hear
• Valeant Judge OKs $23M To End 'Secret' Pharmacy RICO Suits
• Maker Of Recalled COVID-19 Tests Accused Of False Labeling
• MyChart Maker Wants Protection From NPE's Patents
• 9th Circ. Boots COVID-19 Death Suit Back To Calif. State Court
• Pa. Court Says Man Can't Pin Tardy Med Mal Suit On Pandemic
• Patient Death Suit Partially Restored Against Mass. Hospital
• High Court Asks DOJ For Opinion On Medical Pot Payments
• Costco Reaches Deal To End COBRA Notice Language Suit
• Stryker Must Face FCA Claim In Medical Device Fraud Suit
• Health Co. Asks High Court To Rein In FCA Pleading Rules
• Self-Evaluative Privilege May Protect Internal Investigations
• UnitedHealth And Change Say Time's Up For DOJ Deal Review
• Texas Doctor Can't Escape Death Suit Over Missed Blood Clot
• Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs
• Nursing Home Co. Must Face Firing Suit Over $3M Refunds
• Justices Won't Review Maine Health Care Worker Vax Mandate
• Dental Clinic Seeks State Review In 2nd Circ. Virus Appeal
• Deciphering Group Health Plan Disclosure Rules Under ERISA
• Hospital Board Says IHS 'Scrambling' To Quell Contract Row
• Sutter's Practices Raised Premiums For SF Workers, Jury Told
• BlackRock Pens Tribute To CRO, And Other People Moves
• NJ Medical Pot Hopefuls Say Agency Snubbed Court Ruling
• Dr. Asks 9th Circ. To Restart DaVita Unnecessary Care Suit
• Cannabis Bill Roundup: Legalization Bids In The Heartland
• J&J Talc Unit Says Ch. 11 Only Recovery Option For Claimants
• NJ Health System Aims To Toss Breach Suit Over ER Contract
• DC Circ. Is Urged To Greenlight COVID-19 Death Suit
• Prenatal Defect Test Maker Hit With Suit Over False Positives
• Texas Jury Orders Health Center To Pay $2.7M In FCA Case
• 6th Circ. Ends Suits Challenging OSHA's Vax-Or-Test Rule
• Walter Dellinger's Little-Known, Outsize Impact On Legal Aid
• Health Hires: Horizon Therapeutics, Zynerba
• B. Braun Class Cert. Will Await 3rd Circ. ERISA Ruling
• Union Sues Die Cast Manufacturer Over Absent Health Plans
• Trainer In Horse Doping Scheme Deserves 3 Years, Feds Say
• Clark Hill Health Care Atty Joins Waller Lansden In Austin
• Sacklers Offer Another $1.6B For Purdue Ch. 11 Settlement
• FCC Floats $45M Fine Against Health Insurance Robocaller
• Ex-Sutter CFO Denies Flexing Market Muscle At Antitrust Trial
• Talc Claimants Say J&J Unit's Ch. 11 Benefits Parent Co. Only
• Old Settlements Doom Some Doctors' BCBS Antitrust Claims
• DOD Wants 5th Circ. To Narrow Injunction In COVID Vax Case
• 7th Circ. Asked To Revive FCA Suit Over Cook County Grants
• FTC, Rhode Island AG Move To Block Hospital Merger
• Attys From Four Firms Named To Co-Lead Philips CPAP MDL
• Nurse, Marine Reservist Charged With Selling Fake Vax Cards
• Why I'll Miss Arguing Before Justice Breyer
• How Investors Can Navigate A Vibrant Digital Health Market
• Amid Historic Spending, Congress Should Strengthen FCA
• Medicare Fraud Conspiracy Case Beats Trial Delay Challenge
• Judge Axes HHS Letter Over AstraZeneca Discount Dodging
• Australian Condom Co. Takes 'Naked' TM Fight To Court
• SG Tells Justices To Skip Review Of $420M Trade Secrets Row
• Castlight Investor Sues In Del. To Probe $370M Vera Deal
• Insurer Fights Minn. Dentist's 5th Circ. Virus Coverage Appeal
• Calif. Nursing Home Can't Arbitrate Patient Death Suit
• 5th Circ. Backs Workers Fighting United Airlines Vax Mandate
• NY Cannabis Regulators Approve New Medical Pot Rules
• Purdue Gets OK For 2-Week Opioid Suit Freeze Extension
• New 'Public Charge' Rule Excludes Noncash Benefits
• Invisalign Must Face Fed Antitrust Claims, Some State Claims
• Endo Urges Opioid Judge's DQ For 'Egregious' Ethics Lapses
• Pfizer Prevails In Proposed Class Action Over Chantix Recall
• FTC, Weight Loss Co. Ink Deal To Safeguard Kids' Privacy
• Ex-VA Health Official Questions Sutter Costs At Antitrust Trial
• 3rd Circ. Revives Aetna's Bid To Seal Docs In Hospital Suit
• '150 Billion Pills' Gaffe Imperils NY AG's Opioid Win Over Teva
• Tesla, Comcast, Dell, Mylan Join Tech Cos. In Fighting Fintiv
• Texas Sues Biden Over Air Travel Mask Mandate
• Ohio Hospital Must Produce Doctor's File In Malpractice Suit
• Ex-Pharma CEO Wants Landmark Opioid Conviction Tossed
• Calif. Gets Pay-For-Delay Ban Partially Revived
• Air Force Can't Make Unvaccinated Ga. Officer Retire
• What Cos. Can Learn From The 2021 FCA Recovery Statistics
• Calif. Says Oakland Pollution Impacts Black, Latino Health
• Austrian Pharma Co.'s €142M Award Nixed In Germany
• Pension Fund Sues For Docs On $23.8B Cerner-Oracle Deal
• Suit Claiming NJ Atty Botched Med Mal Case Sent To Mediator
• Cities, Tribes, Schools Fight Toss Of McKinsey Opioid MDL
• DOL Sues Pa. Home Care Company, Charging Wage Violations
• UnitedHealth Wants High Court Review Of Medicare Rule
• DOJ Pans Glenmark 'Fishing Expedition' For Grand Jury Docs
• Recent Rulings Show Lawyer Criticism Of Judges Is Perilous
• Ch. 11 For J&J Talc Unit Only Wise Choice, Top Lawyer Says
• Sutter's Prices 'Difficult To Justify,' Antitrust Jury Hears
• DOJ Fraud Section Roars Back From Pandemic Conviction Dip
• 'Failed Experiment' Licensing Not Irrational, 6th Circ. Says
• Med Co. Trims But Can't Ax Spinal Implant Patent Suit
• Texas Doc Must Face Suit Over 7-Year-Old Boy's Injured Eyes
• House Dems Push Biden Admin. To Justify Migrant Expulsions
• Takeaways From DOJ Fraud Section's 2021 Year In Review
• McGuireWoods Adds Ex-BakerHostetler Health Atty In Atlanta
• CVS Wants Consolidated Drug Pricing Suit In Arbitration
• Medline Seeks End To Hartford's Libel Suit Coverage Fight
• Breyer's Role In Courthouse Design Sets A Judicial Template
• In Close Vote, Senate Confirms Califf To Head FDA
• Abrams Fensterman Adds Criminal Defense Group Chair
• Sutter Hospitals Forced On Insurers, Antitrust Trial Jurors Told
• Fla. Health System To Pay $5.5M For Barred Medicaid Funding
• Endo Opioid Saga 'Like A John Grisham Movie,' Judge Says
• Talc Claimants Argue Bad Faith In J&J Unit's Ch. 11 Trial
• Lab Owners Must Face $24M Medicaid Overpayment Claims
• Contractor, Investors Reach $3.3M Deal In COVID Tests Suit
• Tribal Hospital Sues Gov't For Cutting Funding By 90%
• Okla. Rolled Out Medical Pot Too Quickly, Watchdog Finds
• Ark. Pot Cos. Say State's New Rules Are Unconstitutional
• Mallinckrodt Seeks Last Extension Of Ch. 11 Acthar Suit Pause
• Pacific Life Loans $260M For Philly Project
• Expect Aggressive Life Sciences Enforcement In 2022
• All But 2 Claims Trimmed In Pa. Pelvic Mesh Case
• Hotel Group Urges High Court To Kill Seattle Benefits Law
• Pfizer Hits Teva With Suit Over Arthritis Drug Patent
• Bioness Stockholders Challenge $110M Sale To Bioventus
• Real Estate Rumors: Moskovits, GL Homes, AccentCare
• California Biotech Co. Appoints 1st General Counsel
• Pa. AG Says Philadelphia Vaccine Nonprofit Must Dissolve
• TeamHealth To Pay $15M To End Doctor Bonuses Suit
• Alcoa Retirees Want Class Status In Lifetime Benefits Suit
• Ky. Hospital Can't Escape Death Suit Over Wrong CT Scan
• 5 Key Details As Endo Is Rocked Again By Opioid Default
• FDA Won't OK Pfizer's Under 5 Vax Until 3-Shot Study Is Done
• Sutter Exec Defends Contract Terms In $411M Antitrust Trial
• Taiwanese Pharma Co. Says €142M Award Can't Be Enforced
• Fed. Circ. Upholds J&J's Win In Surgical Tool IP Fight
• Cannabis Bill Roundup: A Cure For Hemp's THC Headaches?
• 3rd Circ. Sees Case Law Disfavoring ERISA Class Cert. Appeal
• 7th Circ. Sides With Gov't In Suit Over Post-Surgery Death
• 4 Emerging Trends To Watch In COVID-19 Fraud Enforcement
• What Happened In Flint: Trial To Pull Back Curtain On Crisis
• Feds' Bid To Pause Block On Workers' Vax Mandate Denied
• ​​​​​​​FTC Mulls Asking PBM To Probe Effects On Competition
• FTC No Longer Pressing For Caris Docs In Illumina Case
• Health Hires: Reed Smith, McGuireWoods
• 10th Circ. Revives Call Center Worker's Bias Suit
• Texas Cardiologist Wants Hospital's Antitrust Claims Tossed
• DC Circ. Affirms FCC's Expanded Wireless Antenna Rules
• Sober Home's Medical Chief Convicted Of $110M Billing Fraud
• Law Professors Say J&J Talc Ch. 11 Is Shielding Assets
• 2 Firms Get $12.2M For $45M Surgery Partners Suit Settlement
• Endo Hit With New Default Ruling In Opioid Discovery Debacle
• Walgreens OK'd To Pursue Crowell & Moring Breach Claims
• Wash. Lays Out $38B Opioid Abatement Plan To Trial Judge
• Sutter's Anti-Competitive Tactics 'Gouge' Clients, Jury Hears
• Astellas Workers Win Class Cert. In Suit Over 401(k) Losses
• J&J Unit Says Ch. 11 Is Best Response To Talc Suit 'Tsunami'
• Fla. Clinics Can't Ditch Gilead's HIV Drug Charity Scam Claims
• 5th Circ. Grants New Trial Over Sanofi Chemo Drug
• Cook County Signs Off On $6.75M Med Mal Deal
• Clinic Dodges $50M Punitive Verdict In $7.6M Ga. Judgment
• Expert Report Defects Doom Pa. Patient Death Suit
• Nursing Home Biz Gets Nod For Ch. 11 Facility Sale Plans
• GAO Says CMS Improperly Combined $27M Contract Bids
• Aetna Ordered To Pay More For Mental Care In ERISA Suit
• J&J Can't Be Allowed To Dodge Civil Justice With Bankruptcy
• Norton Rose Nabs Health Care Pros From Morgan Lewis
• 3M Wants High Court Look At Surgical Blanket Expert Ruling
• Ruling Highlights Key Intersection Of 2 Health Benefit Laws
• NY Court Revives Suit Over ER Patient's Fatal Hemorrhage
• Boston Hospitals Say Vax Rule Must Survive 1st Circ. Review
• Split 5th Circ. Won't Stay Block Of Fed. Worker Vax Mandate
• Ex-NFL Player, Health Plan Fraud 'Ringleader' Gets 5 Years
• Mo. Justices Say Winning Pot License Applications Are Public
• Fed. Circ. Says Army Corps Must Pay Specified Bank Account
• Texas Wants National Guard Vaccine Mandate Halted
• SmileDirect Judge Won't Pause Slow-Moving Antitrust Case
• Racehorse Trainers, Vet Can't Dump Doping Scheme Charges
• Groups Urge Biden Admin. To Halt New Gulf Oil Exploration
• Workers In Calif. Eligible For Paid COVID Time With New Law
• Blood Filter Co. Can't Withhold Financial Records In Mass Tort
• Big Names Join COVID Coverage Fights In Turning Point
• Zetia Buyers Defend Class Cert. As 'Common Business Sense'
• Hospital Says Insurer's Settlement Suit Belongs In State Court
• Suit Says Aetna's Fertility Treatment Policy Is Discriminatory
• Greenberg Traurig Adds Shareholders To LA Corporate Group
• Real Estate Rumors: Terra, Bison, WeWork
• NY Judge OKs Canadian Entities' Late Purdue Ch. 11 Appeal
• Medtronic Can't Ditch All Claims In Faulty Pacemaker Suit
• 2 FTC Settlements Guide On Consumer Review Best Practices
• BigLaw Must Nix All-Or-Nothing Work Model To Retain Talent
• Cooperator In Meningitis Outbreak Case Gets Time Served
• New FCA Stats Fuel Debate Over Health Enforcement Fixation
• Feds Fight Alford Plea For Ex-Prof Accused Of Insider Trading
• Maine's Pot Residency Rule Unconstitutional, 1st Circ. Told
• Court Boots Mootness Fee Bid In Microsoft Merger Challenge
• Opioid Crisis In Wash. State 'Unique,' Judge Told
• Lost Theranos Data 'Paints Picture Of Deception,' Judge Says
• Senators Hear Possible Solutions To 'Texas Two-Step' Issues
• FSD Pharma Says Delaware Suit Belongs In Ontario
• DOJ Wants To Build On DaVita Win In No-Poach Cases
• Fla. Justices Mull Medicare Expenses Math In Injury Suits
• Univ. Of Calif. To Pay $244M To End Doctor Sex Abuse Claims
• Sun Pharma, Lupin Agree To Drop Eye Pain Patent Dispute
• Ohio Justice Likens Virus Coverage Issue To Fogged Mirror
• Compliance Hires Of '22 Reflect US Cyber, Corruption Focus
• Canadian Entities Seek Late Appeal In Purdue Ch. 11 Case
• Oracle Gives DOJ More Time To Review $28B Cerner Deal
• Biogen Hid Issues With Alzheimer's Drug, Investor Suit Claims
• Biden's Supreme Court Nominee Should Have 5 Key Qualities
• Distributor Can't Get Coverage For Missing Medical Equipment
• GM Slapped With Class Action Over Benefits Notices
• Using Insurance Coverage To Fund Early Settlement
• Teligent Lender Slams Creditor Group Bid To Claw Back Cash
• 1st Circ. Spots 'Gap' In Cancer-Drug Suit Against Karyopharm
• Ex-Spine Doc Owes $13M To Women Over Faulty Surgeries
• Harvard Prof Says China-Ties Conviction Too Flimsy To Stand
• Calif. Lawmakers OK More Paid COVID Leave For Workers
• J&J Drops Bid To Block Reuters Story As Attys Trade Barbs
• Sutter Antitrust Jurors Will Be COVID-19 Boosted, Judge Says
• Generics Co. Accuses Ex-Exec Of Swiping Trade Secrets
• FDA Probing Possible Death Risk Of Lymphoma Drug
• Engineering Co. Can't Escape Flint Water Negligence Claim
• Inside The New Guidance On Federally Funded Research
• 3rd Circ. Rejects Rehearing Bid In COVID Death Suits
• Minn. Bill Seeks Subtraction Of Health Providers' Virus Aid
• Airline Group, San Francisco Spar Over Health Care Ordinance
• Texas Strikes $225M Deal With Teva Over Opioid Crisis
• AstraZeneca, Merck Want Calquence Generics Halted
• Colo. Bill Would Allow Deduction For Medical Costs
• Law360 Seeks Members For Its 2022 Editorial Boards
• Boston Teachers Sue Over Denied Remote Work In Pandemic
• Flint Residents' Attys Awarded $39.6M As Part Of Water Deal
• Ex-Theranos Exec Seeks To Block Holmes Trial Evidence
• Reuters Says J&J Too Late To Nix Story Over Atty Leak Claim
• Health Provider Says Rival Funded TCPA Suit To Seize Market
• Insurer Can't Fully Escape Clinic's $150M Virus Coverage Suit
• Anesthesiology Group Puts To Rest Drugmaker's Libel Suit
• Cannabis Bill Roundup: SAFE Banking Passes House — Again
• UnitedHealth Units Beat ERISA Drug Overcharge Claim
• Payment Co. Founder's Rant May Not Cost Him $27M After All
• Shkreli's Lifetime Pharma Ban Upheld
• Connecticut Hospital Can't Undo $3.2M Verdict In Injury Suit
• Gulf Coast Asks To Hand Over One Of Last Facilities In Ch. 11
• EU Suspends Deadline For ​​​​​​​Illumina's $8B Grail Deal
• 7th Circ. Axes Sexual Assault Suit Against Chicago Paramedic
• Biden Extends Pandemic Border Block Amid Legal Challenges
• Final Approval In Glumetza Antitrust Deal Gives Attys $50M
• 2 Recent Decisions Highlight Ambiguity As FCA Defense
• Policyholder Attys Eye Ohio Justice's Role In COVID-19 Fight
• Lawyer Wants To Arbitrate NFL Player's Billing Dispute
• Ex-NECC Execs Seek New Trial After Revived Convictions
• Miles & Stockbridge Health Care Team Adds Principal
• Feds Say J&J Talc Trust Can't Exclude Medicare Claims
• Purdue Asks For New Extension On Opioid Suit Freeze
• Anthem Wants Ga. Justices To Step Into Contract Fight
• Philly, Pittsburgh DAs Lose Bid To Stop Opioid Settlement
• Mallinckrodt Ch. 11 Plan Gets Green Light From Del. Court
• J&J Says Talc Plaintiff Attys Fed Confidential Docs To Reuters
• Opioid Trial In Wash. State Briefly Interrupted For Evacuation
• Lack Of ID Theft Dooms Medical Data Breach Suit, Judge Says
• Calif. Judge Unpersuaded To Nix Drugmakers' Opioid Trial Win
• Ex-UChicago Prof Seeks Alford Plea Over Insider Trades
• DaVita Subsidiary Sues Landlord Over Unsafe Philly Building
• Texas Justices Consider Doc's Liability In Teen Suicide Case
• 7th Circ. Scolds VA For 'Runaround' In Worker Malpractice Suit
• UnitedHealth Workers Win Class Cert. In ERISA Suit
• Scholar Briefs OK'd In J&J Talc Unit's Ch. 11 Dismissal Bid
• Upcoming Rulings Key To Defining PREP Act Protections
• Texas Justices Told Blue Cross Can't Get $3M Tax Refund
• GAO Says VA Reasoning Was Sound In $735M IT Deal
• Vision Center And Owner Remain In Pared Down FCA Suit
• Hospital Shooting Suit Not Blocked By NY Workers Comp Law
• Judge Ordered DOJ Atty To Remove Mask, Watchdog Says
• Lifetime Ban For Shkreli Means Lifetime Ban, FTC Says
• Summer Trial Teed Up For Atty Accused Of $8M Escrow Fraud
• Deals Rumor Mill: Novartis, Cedar Fair, IVI-RMA
• NFL Health Plan Fraud 'Ringleader' Faces Up To 9 Years
• Health Care Group Of The Year: Williams & Connolly
• Mississippi Legalizes Medical Pot After Governor's Signature
• BCBS Unit's $28M Shkreli Deal Poised For Initial OK
• Feds Sue Hawaii Health Dept. Over Fuel Storage Order
• Drug Distributor Stymied On FDA Topics In Wash. Trial Cross
• Hawaiian Airlines Workers Can't Block Vaccine Mandate
• Florida Governor Exits Challenge To Ban On Trans Athletes
• Feds Charge 4 In Death Of 'The Wire' Actor Michael K. Williams
• Glenmark Wants Grand Jury Evidence In Price-Fixing Case
• JPML Sends False Ad Suits Over Sleep Device Cleaners To Pa.
• Biden Nominates Michigan District Judge To 6th Circ.
• 5th Circ. Urged To Revive Texas' School Mask Mandate Ban
• Ex-Drug Co-Op CEO Convicted In Landmark Opioid Case
• Pfizer Says Ex-Execs Swiped Data For Rival Drug Startups
• The Flaws In The Traditional Approach To Hiring A Law Firm
• Taxotere Eye Damage Suits Consolidated In Louisiana MDL
• Gerber Accused Of Cutting Anti-Competitive Deal With Perrigo
• Health Care Group Of The Year: Sheppard Mullin
• Man Gets 2nd Shot At Death Suit After Atty Ditches Firm
• Latham-Led Great Hill Lands $4.7B For Latest Fund
• Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight
• How Rx Drugs Become Illegal Street Sales Murky, Judge Told
• At Fed. Circ., Novartis Rips Amgen's 'Patent Estate'
• Shkreli Fights Scope Of Pharma Industry Ban
• UPMC Says Hospital Does Not Owe More To Pension Fund
• 1st Circ. Revives Most Of Raytheon Benefits Denial Suit
• High Court Urged To Take Up Medical Pot Reimbursements
• DOJ Recovers $5.6B In 2021 For 2nd-Highest FCA Haul
• Pfizer Wants FDA's Approval Of COVID Vax For Kids Under 5
• Feds Secure Plea In 1st COVID-19 Health Provider Fraud Case
• Law360's Tort Report: Whitey Bulger Death Suit Thrown Out
• Calif. Single-Payer Health Care Tax Package Dead For Now
• Hospital Can't Avoid Suit Over Harvest Of Daughter's Organs
• GAO Nixes IT Co.'s Protest Of $26M Health Agency Contract
• Purdue Closing In On New Ch. 11 Deal With Sackler Family
• 7th Circ. Rejects UnitedHealth's Class Certification Appeal
• Health Care Group Of The Year: Ropes & Gray
• Tribes Reach $590M Opioids Deal With J&J, Distributors